NWPF

News ArchivesRead News

Israeli Study Finds Smoking Might Help Prevent Parkinsons Disease

Wednesday August 29, 2012

Israeli and Italian researchers are one step closer to discovering a treatment for Parkinson’s disease
Shanghai Daily

Shalom Life - Israeli researchers are one step closer to discovering a treatment for Parkinson’s disease, after finding a genetic mechanism connected to cigarette smoking that keeps the degenerative disease from progressing.

The team of Israeli researchers, who have been engaged in the study since 2000, announced their results earlier this month in the Parkinson and Related Disorders medical journal.

The findings determined a link between nicotine dependence and a protective mechanism which prevents the development of the disease.

The current study was conducted by a team of Israeli scientists from the Hadassah University Hospital, The Hebrew University of Jerusalem, Belinson Hospital and Tel Aviv University, as well as an Italian research institute.

Out of 677 Parkinson patients that were tested, 438 never smoked, while 239 do or used to.

According to the study, the CHRNB5, CHRNB4 and CHRNB3 genes become dependent on nicotine and at the same time are responsible for preventing the progress of the illness.

The discovery helped researchers understand exactly how nicotine prevents the damage to the brain chemical dopamine, which researchers believe to be connected to the development of the illness.

“The combination of genes we identified is important as it allows us to better understand the mechanism by which smoking reduces the likelihood of Parkinson’s,” team director Prof. Benjamin Lerer, director of the Psychiatric Biology Laboratory in Hadassah Ein Karem hospital, told the Ha’aretz daily.

However, he stressed that smoking-related illnesses outweigh the benefits, and that they are looking for a new treatment aimed at the genes they have discovered — which does not include the hazardous habit.

The link between smoking and Parkinson’s disease prevention was first established in a 2001 report published in the medical journal Epidemiology.

It then found that people who smoke (or used to smoke in the past) are 60 percent less likely to develop the disease, which damages the central nervous system, than non-smokers.

Additionally, past research found other positive influences of nicotine, among them, in bettering concentration and memory, as well as helping schizophrenics control their symptoms.

http://ca.shalomlife.com/health/17813/israeli-study-finds-smoking-might-help-prevent-parkinsons-disease/

Recent News

Jun 13 - Brain Cell Transplants Are Being Tested Once Again For Parkinson's
Jun 12 - Smell Test May Sniff Out Oncoming Parkinson's and Alzheimer's
Jun 8 - Smartphones Track Motor Function in Parkinson's Disease
Jun 8 - GKC Enrolls First Patient in Personal KinetiGraph Trial as Part of NPF’s Parkinson’s Outcomes Project
Jun 8 - Low-fat dairy intake may raise Parkinson's risk
Jun 6 - Patient Voices: Parkinson's Disease
Jun 1 - World-First Trials Have Been Launched to Treat Parkinson's And Blindness With Embryonic Stem Cells
May 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis